Connect your AI

PTHS PTHS Debt Repayments

Debt Repayments at other companies

Scilex Holding CompanySCLX

——

Zevra Therapeutics, Inc.ZVRA

——

Other financials

Income statement

Revenue$10.9M—

Gross profit$9.2M—

Operating income-$13.1M-614%

Net income-$10.2M-420%

EPS (diluted)-$3.09+3.7%

Balance sheet

Cash & equivalents$32.0M+24,250%

Total debt$29.6M—

Total equity$35.1M+937%

Total assets$145.4M+15,855%

Cash flow

Operating cash flow-$13.1M-1,977%

CapEx$194.0K—

Free cash flow-$13.3M-2,008%

Valuation

Market cap$98.22M+75.4%

Enterprise value$95.89M—

P/S3.6×—

Profitability

Gross margin79.6%—

Operating margin-157.7%—

Net margin-186.2%—

FCF margin-60.8%—

Returns & leverage

Return on equity-333.8%—

Debt / equity0.8×—

Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfDebt.

The official record: PTHS’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is PTHS's debt repayments?: PTHS (PTHS) reported debt repayments of $211.25K in Q4 2025.
How has PTHS's debt repayments changed year-over-year?: PTHS's debt repayments increased by 293.0% year-over-year, from $53.75K to $211.25K.